Rapport mondial sur le diabète, 2016. ,
Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, pp.62-69, 2010. ,
Structural biology of insulin and IGF1 receptors: implications for drug design, Nature Reviews Drug Discovery, vol.297, issue.10, pp.769-83, 2002. ,
DOI : 10.1126/science.1074611
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog, The EMBO Journal, vol.16, issue.18, pp.5572-81, 1997. ,
DOI : 10.1093/emboj/16.18.5572
Insulin signalling and the regulation of glucose and lipid metabolism, Nature, vol.414, issue.6865, pp.799-806, 2001. ,
DOI : 10.1038/414799a
Does Mitogen-Activated-Protein Kinase have a Role in Insulin Action?, FEBS J, vol.227, issue.3, pp.597-611, 1995. ,
Mitogen-activated Protein Kinase Kinase Inhibition Does Not Block the Stimulation of Glucose Utilization by Insulin, Journal of Biological Chemistry, vol.268, issue.35, pp.20801-20808, 1995. ,
DOI : 10.1021/bi00184a031
Que nous apprennent les souris génétiquement modifiées sur la physiopathologie du diabète de type 2 ? Médecine Thérapeutique Endocrinol, pp.53-62, 2002. ,
Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes, vol.49, issue.2, pp.284-92, 2000. ,
DOI : 10.2337/diabetes.49.2.284
Insulin resistance differentially affects the PI 3-kinase??? and MAP kinase???mediated signaling in human muscle, Journal of Clinical Investigation, vol.105, issue.3, pp.311-331, 2000. ,
DOI : 10.1172/JCI7535
Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology, Diabetes, vol.53, issue.11, pp.2735-2775, 2004. ,
DOI : 10.2337/diabetes.53.11.2735
Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulindependent diabetes mellitus, Proc Natl Acad Sci Feb, vol.1492, issue.4, pp.983-990, 1995. ,
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Diabetes, vol.58, issue.4, pp.773-95, 2009. ,
DOI : 10.2337/db09-9028
Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients, Diabetes, vol.50, issue.6, pp.1363-70, 2001. ,
DOI : 10.2337/diabetes.50.6.1363
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake, Metabolism, vol.38, issue.4, pp.387-95, 1989. ,
DOI : 10.1016/0026-0495(89)90129-7
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., Journal of Clinical Investigation, vol.90, issue.4, pp.1323-1330, 1992. ,
DOI : 10.1172/JCI115997
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Diabetes, vol.58, issue.4, pp.773-95, 2009. ,
DOI : 10.2337/db09-9028
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes, Diabetes, vol.49, issue.6, pp.969-74, 2000. ,
DOI : 10.2337/diabetes.49.6.969
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study, Diabetes, vol.49, issue.8, pp.1367-73, 2000. ,
DOI : 10.2337/diabetes.49.8.1367
Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals, Metabolism, vol.51, issue.9, pp.1111-1120, 2002. ,
DOI : 10.1053/meta.2002.34700
Control mechanisms of gluconeogenesis and ketogenesis. II. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver, J Biol Chem, vol.244, issue.17, pp.4617-4644, 1969. ,
Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM, Diabetes, vol.39, issue.11, pp.1381-90, 1990. ,
DOI : 10.2337/diab.39.11.1381
Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients, Diabetes, vol.49, issue.4, 2000. ,
DOI : 10.2337/diabetes.49.4.647
Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha, Diabetes, vol.49, issue.11, 2000. ,
DOI : 10.2337/diabetes.49.11.1904
Insulin Resistance Is Associated with Impaired Nitric Oxide Synthase Activity in Skeletal Muscle of Type 2 Diabetic Subjects, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.2, pp.1100-1105, 2005. ,
DOI : 10.1210/jc.2004-0745
Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size, J Clin Invest, 1974. ,
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity, Expert Review of Cardiovascular Therapy, vol.91, issue.3, pp.343-68, 2008. ,
DOI : 10.1210/jc.2005-2069
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia, pp.824-857, 2001. ,
Dysfunctional fat cells, lipotoxicity and type 2 diabetes, International Journal of Clinical Practice, vol.100, issue.Suppl. 2, pp.9-21, 2004. ,
DOI : 10.1249/00003677-199600240-00009
The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.1, pp.96-107, 1991. ,
DOI : 10.1210/jcem-72-1-96
THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS, The Lancet, vol.281, issue.7285, 1963. ,
DOI : 10.1016/S0140-6736(63)91500-9
Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes, Diabetes, vol.49, issue.3, pp.399-408, 2000. ,
DOI : 10.2337/diabetes.49.3.399
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus., Journal of Clinical Investigation, vol.96, issue.1, pp.520-527, 1995. ,
DOI : 10.1172/JCI118064
Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes, Diabetes, vol.44, issue.5, pp.506-518, 1995. ,
DOI : 10.2337/diab.44.5.506
Use and Abuse of HOMA Modeling, Diabetes Care, vol.27, issue.6, pp.1487-95, 2004. ,
DOI : 10.2337/diacare.27.6.1487
UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease, Diabetes, vol.44, issue.11, pp.1249-58, 1995. ,
??-Cell Deficit and Increased ??-Cell Apoptosis in Humans With Type 2 Diabetes, Diabetes, vol.52, issue.1, pp.102-112, 2003. ,
DOI : 10.2337/diabetes.52.1.102
URL : http://diabetes.diabetesjournals.org/content/diabetes/52/1/102.full.pdf
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Pathol Immunopathol Res, vol.4, issue.2, pp.110-135, 1985. ,
An ultrastructural analysis of the developing embryonic pancreas, Developmental Biology, vol.29, issue.4, pp.436-67, 1972. ,
DOI : 10.1016/0012-1606(72)90083-8
Islet Cell Replication and Diabetes, pp.141-70978, 1007. ,
DOI : 10.1007/978-3-642-72691-0_9
How obesity causes diabetes in Zucker diabetic fatty rats, Trends in Endocrinology and Metabolism, vol.8, issue.7, pp.276-82, 1997. ,
DOI : 10.1016/S1043-2760(97)00094-5
Islet Amyloid and Type 2 Diabetes Mellitus, New England Journal of Medicine, vol.343, issue.6, pp.411-420, 2000. ,
DOI : 10.1056/NEJM200008103430607
Traité de diabétologie. Paris: Flammarion médecine-sciences, 2009. ,
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans: A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program, Diabetes, vol.50, issue.6, pp.1290-301, 2001. ,
DOI : 10.2337/diabetes.50.6.1290
Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes, New England Journal of Medicine, vol.318, issue.19, pp.1225-1255, 1988. ,
DOI : 10.1056/NEJM198805123181902
Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes, 1995. ,
The biology of incretin hormones, Cell Metabolism, vol.3, issue.3, pp.153-65, 2006. ,
DOI : 10.1016/j.cmet.2006.01.004
Incretins and the development of type 2 diabetes, Current Diabetes Reports, vol.50, issue.suppl 1, pp.194-201, 2006. ,
DOI : 10.1152/ajpendo.00452.2001
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.8, pp.3717-3740, 2001. ,
DOI : 10.1210/jcem.86.8.7750
Reduced insulinotropic effect of gastric inhibitory polypeptide (GIP) in first-degree relatives of type 2 diabetic patients, Diabetes Research and Clinical Practice, vol.50, issue.5, pp.227-227, 2000. ,
DOI : 10.1016/S0168-8227(00)81589-2
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes, AJP: Endocrinology and Metabolism, vol.294, issue.5, pp.846-852, 2008. ,
DOI : 10.1152/ajpendo.00030.2008
Documentation of Hyperglucagonemia Throughout the Day in Nonobese and Obese Patients with Noninsulin-Dependent Diabetes Mellitus*, The Journal of Clinical Endocrinology & Metabolism, vol.64, issue.1, pp.106-116, 1987. ,
DOI : 10.1210/jcem-64-1-106
Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals, Metabolism, vol.51, issue.9, pp.1111-1120, 2002. ,
DOI : 10.1053/meta.2002.34700
Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus, Endocrine Practice, vol.14, issue.6, pp.782-90, 2008. ,
DOI : 10.4158/EP.14.6.782
Role of brain insulin receptor and control of body weight and reproduction, Experimental and Clinical Endocrinology & Diabetes, vol.114, issue.08, pp.2122-2127, 2000. ,
DOI : 10.1055/s-2006-954676
Altered hypothalamic function in response to glucose ingestion in obese humans, Diabetes, vol.48, issue.9, pp.1801-1807, 1999. ,
DOI : 10.2337/diabetes.48.9.1801
Pathogenesis of type 2 diabetes mellitus, Med Clin, vol.88, issue.4, pp.787-835, 2004. ,
Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2 Diabetes Development, Diabetes Care, vol.24, issue.1, pp.89-94, 2001. ,
DOI : 10.2337/diacare.24.1.89
Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use, The American Journal of Medicine, vol.122, issue.6, pp.37-50, 2009. ,
DOI : 10.1016/j.amjmed.2009.03.015
Stratégie médicamenteuse du contrôle glycémique du diabète de type 2 [Internet] Available from: https://www.has-sante, pp.2013-2015, 2017. ,
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, vol.38, issue.1, pp.140-149, 2015. ,
DOI : 10.2337/dc14-2441
Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes, Annals of Internal Medicine, vol.166, issue.8, p.572, 2017. ,
DOI : 10.7326/M16-2937
Precision diabetes: a realistic outlook on a promising approach, Diabetologia, vol.11, issue.5, pp.766-774, 2017. ,
DOI : 10.1007/s00125-017-4227-1
URL : https://link.springer.com/content/pdf/10.1007%2Fs00125-017-4244-0.pdf
Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes, Diabetes, Obesity and Metabolism, vol.20, issue.2, pp.67-74, 1999. ,
DOI : 10.2337/diacare.20.9.1353
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis, The Lancet Diabetes & Endocrinology, vol.1, issue.1, pp.28-34, 2013. ,
DOI : 10.1016/S2213-8587(13)70006-8
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods, The American Journal of Cardiology, vol.99, issue.12, pp.21-33, 2007. ,
DOI : 10.1016/j.amjcard.2007.03.003
Les hypoglycémies chez les diabétiques âgés : conséquences sur les fonctions cognitives. Médecine Mal Métaboliques, pp.383-390, 2011. ,
DOI : 10.1016/s1957-2557(11)70270-x
Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.2, pp.659-68, 2016. ,
DOI : 10.1210/jc.2015-3169
Cost and co-morbidities associated with hypoglycemic inpatients in Belgium, Journal of Medical Economics, vol.19, issue.1, pp.44-52, 2016. ,
DOI : 10.3111/13696998.2015.1086775
??-cell dysfunction: Its critical role in prevention and management of type 2 diabetes, World Journal of Diabetes, vol.6, issue.1, pp.109-133 ,
DOI : 10.4239/wjd.v6.i1.109
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment, Diabetologia, vol.2, issue.1, pp.13-20, 2016. ,
DOI : 10.1016/S2213-8587(14)70050-6
Painting a new picture of personalised medicine for diabetes, Diabetologia, vol.7, issue.5, pp.793-802, 2017. ,
DOI : 10.1126/scitranslmed.aaa9364
The degree of masculine differentiation of obesities a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease, Am J Clin Nutr, vol.4, issue.1, pp.20-34, 1956. ,
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance., Journal of Clinical Investigation, vol.75, issue.3, p.809, 1985. ,
DOI : 10.1172/JCI111776
Role of Insulin Resistance in Human Disease. Diabetes, pp.1595-607, 1988. ,
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men, JAMA, vol.288, issue.21, pp.2709-2725, 2002. ,
DOI : 10.1001/jama.288.21.2709
Imaging-based characterization of cardiometabolic phenotypes focusing on whole-body MRI?an approach to disease prevention and personalized treatment Available from, Br J Radiol [Internet], vol.89, 1059. ,
Evaluation of Abdominal Fat Distribution in Noninsulin-Dependent Diabetes Mellitus: Relationship to Insulin Resistance, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.4, pp.1306-1317, 1998. ,
DOI : 10.1210/jc.83.4.1306
Ectopic fat accumulation: an important cause of insulin resistance in humans, J R Soc Med, vol.95, pp.39-45, 2002. ,
The discriminative ability of waist circumference, body mass index and waist-to-hip ratio in identifying metabolic syndrome: Variations by age, sex and race, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol.9, issue.2, 2015. ,
DOI : 10.1016/j.dsx.2015.02.006
Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes, European Heart Journal Supplements, vol.8, issue.suppl_B, pp.20-25, 2006. ,
DOI : 10.1093/eurheartj/sul004
Insulin Resistance in Essential Hypertension, New England Journal of Medicine, vol.317, issue.6, pp.350-357, 1987. ,
DOI : 10.1056/NEJM198708063170605
The effect of insulin on renal sodium metabolism. Diabetologia, pp.165-71, 1981. ,
Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis, Clinica Chimica Acta, vol.464, pp.57-63, 2017. ,
DOI : 10.1016/j.cca.2016.11.009
Prognostic value of the metabolic syndrome in essential hypertension, Journal of the American College of Cardiology, vol.43, issue.10, pp.1817-1839, 2004. ,
DOI : 10.1016/j.jacc.2003.12.049
Prevalence of metabolic syndrome in hypertriglyceridaemic patients: higher than it may appear, Current Medical Research and Opinion, vol.30, issue.2, 2014. ,
DOI : 10.1185/03007995.2013.856288
The association between triglyceride to highdensity-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort, Metabolism. 2012, vol.61, issue.4, pp.583-592 ,
The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White European and South Asian Men and Women, PLoS ONE, vol.363, issue.166, p.50931, 2012. ,
DOI : 10.1371/journal.pone.0050931.t002
Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups, Journal of Gastroenterology and Hepatology, vol.54, issue.Suppl. 1, pp.664-70, 2013. ,
DOI : 10.1002/hep.24452
C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study, Endocrine, vol.40, issue.suppl, pp.351-360, 2013. ,
DOI : 10.1007/s12020-011-9466-1
Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians, Atherosclerosis, vol.220, issue.1, pp.275-81, 2012. ,
DOI : 10.1016/j.atherosclerosis.2011.10.031
Serum Ferritin as a Component of the Insulin Resistance Syndrome, Diabetes Care, vol.21, issue.1, pp.62-70, 1998. ,
DOI : 10.2337/diacare.21.1.62
Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR), Diabetes Care, vol.30, issue.7, pp.1795-801, 2007. ,
DOI : 10.2337/dc06-2312
Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am J Physiol-Gastrointest Liver Physiol, vol.237, issue.3, pp.214-223, 1979. ,
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp., Journal of Clinical Investigation, vol.79, issue.3, p.790, 1987. ,
DOI : 10.1172/JCI112886
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, Diabetes Care, vol.22, issue.9, pp.1462-70, 1999. ,
DOI : 10.2337/diacare.22.9.1462
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, vol.92, issue.7, pp.412-421, 1985. ,
DOI : 10.1007/BF00280883
Mesurer l'insulinosensibilité en pratique clinique Available from, p.79997, 2008. ,
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, Diabetes Care, vol.23, issue.2, pp.171-176, 2000. ,
DOI : 10.2337/diacare.23.2.171
Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.11, pp.5457-64, 2001. ,
DOI : 10.1210/jcem.86.11.7880
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.7 ,
DOI : 10.1210/jcem.85.7.6661
Pulsatility of insulin and glucagon release: physiological significance and pharmacological implications, Diabetologia, vol.12, issue.4, pp.443-52, 1987. ,
DOI : 10.1007/978-3-642-68866-9_13
Physiology and Pathophysiology of Insulin Secretion, Diabetes Care, vol.13, issue.6, pp.655-66, 1990. ,
DOI : 10.2337/diacare.13.6.655
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus, Diabetes/Metabolism Research and Reviews, vol.18, issue.3, pp.164-74, 2001. ,
DOI : 10.2337/diacare.18.8.1156
Current approaches to measurement of insulin secretion, Diabetes / Metabolism Reviews, vol.66, issue.1, pp.3-4315, 1986. ,
DOI : 10.2337/diab.27.1.S197
How to measure insulin clearance, Diabetes / Metabolism Reviews, vol.38, issue.2, pp.119-50, 1994. ,
DOI : 10.1111/j.1532-5415.1990.tb03449.x
Measurement of Insulin Secretion in Type 2 Diabetes: Problems and Pitfalls, Diabetic Medicine, vol.34, issue.suppl 1, pp.503-515, 1992. ,
DOI : 10.1042/bj2600535
Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients, Kidney International, vol.58, issue.4, pp.1742-50, 2000. ,
DOI : 10.1046/j.1523-1755.2000.00335.x
URL : https://doi.org/10.1046/j.1523-1755.2000.00335.x
Assays for Insulin, Proinsulin(S) and C-Peptide, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.36, issue.5, pp.541-64, 1999. ,
DOI : 10.1177/000456329903600501
URL : http://journals.sagepub.com/doi/pdf/10.1177/000456329903600501
Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes, Diabetes Research and Clinical Practice, vol.68, issue.3, pp.202-208, 2005. ,
DOI : 10.1016/j.diabres.2004.10.005
Correlations Between Fasting Plasma C-Peptide, Glucagon-Stimulated Plasma C-Peptide, and Urinary C-Peptide in Insulin-Treated Diabetics, Diabetes Care, vol.10, issue.4, pp.487-90, 1987. ,
DOI : 10.2337/diacare.10.4.487
International Comparison of C-Peptide Measurements, Clinical Chemistry, vol.53, issue.4, pp.784-791, 2007. ,
DOI : 10.1373/clinchem.2006.081570
URL : http://clinchem.aaccjnls.org/content/clinchem/53/4/784.full.pdf
Standardization of C-Peptide Measurements, Clinical Chemistry, vol.54, issue.6, pp.1023-1029, 2008. ,
DOI : 10.1373/clinchem.2007.101287
URL : http://clinchem.aaccjnls.org/content/clinchem/54/6/1023.full.pdf
Simple Measures to Monitor ?-Cell Mass and Assess Islet Graft Dysfunction, American Journal of Transplantation, vol.7, issue.2, pp.303-311, 2007. ,
DOI : 10.1152/ajpendo.00319.2003
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2006.01620.x/pdf
Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes, Metabolism, vol.62, issue.10, pp.1470-1476, 2013. ,
DOI : 10.1016/j.metabol.2013.05.022
Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes, Endocrine Journal, vol.58, issue.4, pp.315-337, 2011. ,
DOI : 10.1507/endocrj.K10E-399
Postprandial C-peptide to glucose ratio as a predictor of ??-cell function and its usefulness for staged management of type??2 diabetes, Journal of Diabetes Investigation, vol.22, issue.Suppl, pp.517-541, 2014. ,
DOI : 10.2337/diacare.10.5.558
The breakfast tolerance test: a return to physiology, Diabete Metab, vol.2, issue.1, pp.15-24, 1976. ,
Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of ??-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series, Diabetes Care, vol.39, issue.9, 2016. ,
DOI : 10.2337/dc15-0931
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes, Diabetes/Metabolism Research and Reviews, vol.31, issue.6, 2017. ,
DOI : 10.1002/dmrr.2647
Glucagon-Stimulated and Postprandial Plasma C-Peptide Values as Measures of Insulin Secretory Capacity, Diabetes Care, vol.11, issue.4, pp.318-340, 1988. ,
DOI : 10.2337/diacare.11.4.318
Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity, Journal of Diabetes Investigation, vol.128, 2017. ,
DOI : 10.7326/0003-4819-128-7-199804010-00001
Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment Available from, J Diabetes Metab Disord [Internet], vol.15, 2016. ,
Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion, Diabetic Medicine, vol.51, issue.3, pp.286-92, 1994. ,
DOI : 10.1042/bj2600535
Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes):987. serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy, Acta Diabetol. J Diabetes Investig, vol.504, issue.66, pp.618-643, 2013. ,
Association between beta cell function and future glycemic control in patients with type 2 diabetes, Endocrine Journal, vol.60, issue.4, pp.517-540, 2013. ,
DOI : 10.1507/endocrj.EJ12-0416
Functional Assessment of Pancreatic ??-Cell Area in Humans, Diabetes, vol.58, issue.7, pp.1595-603, 2009. ,
DOI : 10.2337/db08-1611
Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type???2 diabetes, Journal of Diabetes Investigation, vol.58, issue.4, pp.297-303, 2011. ,
DOI : 10.2337/db08-1611
Postprandial C-Peptide to Glucose Ratio as a Marker of ?? Cell Function: Implication for the Management of Type 2 Diabetes, International Journal of Molecular Sciences, vol.44, issue.5, p.744, 2016. ,
DOI : 10.1210/jc.2016-1374
Epidemic obesity and type 2 diabetes in Asia, The Lancet, vol.368, issue.9548, pp.1681-1689, 2006. ,
DOI : 10.1016/S0140-6736(06)69703-1
Diabetes in the Western Pacific Region???Past, Present and Future, Diabetes Research and Clinical Practice, vol.103, issue.2, pp.244-55, 2014. ,
DOI : 10.1016/j.diabres.2013.11.012
Prospective Study on the Incidences of Cardiovascular-Renal Complications in Chinese Patients With Young-Onset Type 1 and Type 2 Diabetes, Diabetes Care, vol.37, issue.1, pp.149-57, 2014. ,
DOI : 10.2337/dc13-1336
HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population, Diabetic Medicine, vol.19, issue.1, pp.22-30, 2001. ,
DOI : 10.1016/S0140-6736(97)03062-6
Factors associated with glycemic variability in Japanese patients with diabetes, Diabetology International, vol.33, issue.1, pp.36-42 ,
DOI : 10.1007/s00592-012-0441-y
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes, Journal of Diabetes and its Complications, vol.27, issue.1, pp.87-91, 2013. ,
DOI : 10.1016/j.jdiacomp.2012.07.001
Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes, Yonsei Medical Journal, vol.57, issue.6, p.1395, 2016. ,
DOI : 10.3349/ymj.2016.57.6.1395
Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus, Diabetes & Metabolism Journal, vol.35, issue.3, pp.282-291, 2011. ,
DOI : 10.4093/dmj.2011.35.3.282
Antihyperglycaemic Efficacy, Response Prediction and Dose-Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination, Diabetic Medicine, vol.16, issue.supplement, pp.953-60, 1994. ,
DOI : 10.1111/j.1445-5994.1991.tb01375.x
Conclusions:, Clinical Chemistry and Laboratory Medicine (CCLM), vol.54, issue.8, pp.1224-1257, 2017. ,
DOI : 10.1515/cclm-2017-0029